Most importantly, the current evidence supports the involvement of PKC isozymes both in the control of EMT transcription factor expression/activity as well as in the regulation of EMT transcriptional networks, particularly in cancer (22, 71, 135, 139, 246). This evidence concerns the gene PRRT2 and cancer.